DR. Stephen E. Weinroth, MD is an infectious disease internal medicine in Fairfax, VA with 32 years of experience. The provider is an internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine. DR. Stephen E. Weinroth, MD NPI is 1033130430. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1992
The provider's business location address is:
11211 WAPLES MILL ROAD
SUITE 200
FAIRFAX, VA
ZIP 22030-406
Phone: (703) 246-9560
Fax: (703) 246-9564
The NPI 1033130430 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Removal of skin and tissue first 20 sq cm or less (HCPCS:11042)
- Administration of influenza virus vaccine (HCPCS:G0008)
The enumeration date for this NPI number is 7/21/2006 and was last updated on 4/30/2020.